Nectar Lifescience Ltd
₹10.26
+0.12 (1.18%)
Fri, 06 Nov 2026, 09:13 am
Nectar Lifescience News
Nectar Lifesciences adopts FY26 results at AGM
Nectar Lifesciences shareholders approved FY26 financial statements and reappointed key directors including Sanjiv Goyal and two independent directors.
05 Oct 2026
companies
Nectar Lifesciences faces ₹89.32 crore CGST litigation
Punjab and Haryana High Court remanded a CGST matter involving ₹89.32 crore demand back to the Appellate Authority for fresh consideration on September 24, 2026.
03 Oct 2026
companies
Nectar Lifesciences AGM: Auditors give clean opinion
Nectar Lifesciences held its 31st AGM on September 18, 2026. Statutory auditors issued an unqualified opinion for FY26. The board reappointed key directors and adopted financial statements.
18 Sept 2026
companies
Nectar Lifesciences AGM: Board changes, voting dates
Nectar Lifesciences schedules 31st AGM for September 18, 2026. Key agenda items include re-appointing independent directors Dr. Kuldip Kumar Bhasin and Dr. Indu Pal Kaur, appointing Dr. Gunmala Suri as Non-Executive Director, and re-appointing Chairman Sanjiv Goyal.
20 Aug 2026
companies
Nectar Lifesciences extends slump sale deadline
Nectar Lifesciences Ltd has extended the completion date for the slump sale of its empty hard gelatin capsule business to December 31, 2026. The buyer is Capnest Health Care Private Limited.
23 Jul 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo